Local Institution - 6304

Seoul 110-744

0 studies enrolling now · 3 studies all time

What they study most

ALK Gene Mutation, Advanced Solid Tumor, Locally Advanced Solid Tumors, Lymphoma, Metastatic Solid Tumor, Metastatic Solid Tumors, NSCLC, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Primary CNS Tumors

Studies at this site

• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements — Recruiting now
• A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations — Recruiting now
• A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC — Stopped early